Cosmetic Surgery Products

471 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
471
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Cosmetic Surgery Products

  1. 1. INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS CLICK TO VIEW Table of Contents 2 List of Tables & Charts 3 Study Overview 4 Sample Text, Table & Chart 5 Sample Profile, Table & Forecast 6 Order Form 7 About Freedonia, Custom Research, Related Studies, Corporate Use License 8 Cosmetic Surgery Products US Industry Study with Forecasts to 2010 & 2015 Study #2099 | September 2006 | $4300 | 226 pages The Freedonia Group 767 Beta Drive www.freedoniagroup.com Cleveland, OH • 44143-2326 • USA Toll Free US Tel: 800.927.5900 or +1 440.684.9600 Fax: +1 440.646.0484 E-mail: info@freedoniagroup.com
  2. 2. Study #2099 September 2006 $4300 Cosmetic Surgery Products 226 Pages US Industry Study with Forecasts to 2010 & 2015Table of ContentsIntroductIon Lasers ....................................75 Market Share ........................... 146 Hair Removal........................79 Allergan ............................... 149ExEcutIvE Summary Dermal Resurfacing ...............80 Mentor................................. 151 Other ..................................81 Medicis ................................ 152markEt EnvIronmEnt Microdermabrators ...................83 Other Market Leaders ............. 152General ......................................4 Consumables ...........................85 Industry Restructuring .............. 154Demographic Trends .....................5 Liposuction Equipment .............87 Competitive Strategies .............. 156Macroeconomic Outlook ................8 Other.....................................88 Research & Development ........... 158Consumer Spending Outlook.........10 Injectables ...............................90 Cooperative Agreements ............ 159Medical Provider & Facility Trends .12 Botulinum Toxin ......................92 Marketing ............................... 162Spa Industry Outlook ..................15 Tissue Fillers...........................95Competitive Product Trends .........17 Hyaluronic Acid ....................96 comPany ProfILESMedical Product Market Outlook....20 Collagen ..............................99 Allergan Incorporated ............... 165Regulatory Issues.......................23 Other ................................ 102 Artes Medical .......................... 170 Calcium Hydroxylapatite .... 103 BioForm Medical ...................... 171coSmEtIc ProcEdurES All Others........................ 104 Candela Corporation ................. 172General ....................................27 Other................................... 105 Cutera Incorporated ................. 174Surgical ....................................30 Implants................................. 108 Cynosure Incorporated .............. 175 Reshaping ..............................33 Breast Implants .................... 110 DermaMed USA ........................ 178 Lifts & Tucks ...........................35 Types of Breast Implants ...... 112 Diamond International .............. 179 Implants ................................38 Producers .......................... 114 Elan Corporation ...................... 181 Liposuction ............................42 Other Implants...................... 116 ExcellaDerm Corporation ........... 182 Other.....................................44 Lip .................................. 118 Fascia Biosystems .................... 183Nonsurgical ...............................45 Chin & Cheek...................... 119 Genesis Biosystems .................. 184 Injections ..............................48 All Other ........................... 121 Genzyme Corporation ................ 185 Botulinum Toxin ...................50 Wound Care Disposables ............ 122 Hoya Corporation ..................... 187 Soft Tissue Fillers..................51 Bandages & Dressings ............ 123 Immucor Incorporated .............. 188 Hyaluronic Acid ..................54 Wound Closures ..................... 126 IntegreMed LLC........................ 189 Collagen ...........................55 Other................................... 129 Johnson & Johnson .................. 190 Fat ...................................55 Other Cosmetic Surgery Products 130 Laserscope .............................. 192 Other Soft Tissue Fillers .......56 LifeCell Corporation .................. 194 Other Injections ...................58 raW matErIaLS Lumenis Limited ...................... 195 Laser Treatments .....................60 General .................................. 133 Medicis Pharmaceutical ............. 198 Laser Dermal Resurfacing .......61 Biological Materials .................. 134 Mentor Corporation .................. 200 Hair Removal........................62 Microbial Extracts .................. 135 Palomar Medical Technologies .... 203 Other Laser Treatments ..........63 Collagen .............................. 138 Q-Med AB ............................... 206 Dermal Resurfacing ..................64 Other................................... 139 Smith & Nephew ...................... 208 Other.....................................67 Polymers................................. 140 Solstice Neurosciences .............. 209 Other ..................................... 142 3M Company ........................... 210ProductS Tyco International Limited ........ 211General ....................................69 InduStry StructurE Other Companies in the CosmeticEquipment ................................73 General .................................. 145 Surgery Industry ..................... 213 Click here to purchase onlinePage 2 Order now, click here!
  3. 3. Study #2099 September 2006 $4300 Cosmetic Surgery Products 226 Pages US Industry Study with Forecasts to 2010 & 2015List of Tables & ChartsExEcutIvE Summary 11 Soft Tissue Injection 14 Other Injectables Demand 1 Summary Table .......................3 Demand by Type .................53 in Cosmetic Surgery .......... 108 Cht Soft Filler Injection Demand 15 Cosmetic SurgerymarkEt EnvIronmEnt by Type, 1995-2015 ............54 Implants Demand ............. 110 1 Population & Households .........7 12 Other Injection Demand .........59 16 Breast Implants Demand ...... 112 2 Macroeconomic Indicators ......10 13 Laser Treatment Demand 17 Other Cosmetic Implants 3 Personal Consumption by Type.............................61 Demand by Type ............... 118 Expenditures......................12 14 Dermal Resurfacing 18 Cosmetic Surgery Wound Care 4 Medical Providers & Facilities ..15 Treatments Demand by Type .67 Disposables Demand ......... 123 5 Spa Facilities by Type ............17 15 Other Nonsurgical Cosmetic 19 Bandages & Dressings Demand 6 Selected Medical Product Treatment Demand ..............68 in Cosmetic Surgery .......... 126 Demand by Type .................23 20 Wound Closures Demand ProductS in Cosmetic Surgery .......... 128coSmEtIc ProcEdurES 1 Cosmetic Surgery Products 21 Other Wound Care 1 Cosmetic Procedures Demand by Type .................72 Disposables Demand Demand by Type .................29 Cht Cosmetic Surgery Products in Cosmetic Surgery .......... 130Cht Cosmetic Procedures Demand Demand by Type, 1995-2015 72 22 Other Cosmetic Surgery by Type, 1995-2015 ............30 2 Cosmetic Surgery Equipment Products Demand.............. 132 2 Surgical Cosmetic Procedures Demand by Type .................74 Demand by Type .................32 3 Cosmetic Laser Demand raW matErIaLSCht Surgical Cosmetic Procedures by Type.............................78 1 Cosmetic Surgery Demand by Type, 2005 ........33 4 Microdermabrator Demand ......85 Raw Material Demand ........ 134 3 Cosmetic Reshaping 5 Cosmetic Surgery Consumables 2 Biological Materials Demand Procedures Demand by Type .35 Demand ............................86 in Cosmetic Surgery 4 Cosmetic Lift & Tuck 6 Liposuction Equipment Products ......................... 135 Demand by Type .................38 Demand ............................88 3 Polymers Demand in Cosmetic 5 Cosmetic Implant Procedures 7 Other Cosmetic Surgery Surgery Products .............. 142 Demand by Type .................41 Equipment Demand .............90 4 Other Raw Material Demand in 6 Liposuction Procedures 8 Cosmetic Surgery Cosmetic Surgery Products . 144 Demand ............................43 Injectables Demand ............92 7 Other Surgical Cosmetic 9 Botulinum Toxin Demand InduStry StructurE Procedures Demand.............45 in Cosmetic Surgery ............94 1 US Cosmetic Surgery Product 8 Nonsurgical Cosmetic 10 Tissue Fillers Demand Sales by Company, 2005 .... 147 Procedures Demand by Type .47 in Cosmetic Surgery ............96 Cht US Cosmetic SurgeryCht Nonsurgical Cosmetic 11 Hyaluronic Acid Fillers Demand Product Market Share Procedures Demand by Type, in Cosmetic Surgery ............99 by Company, 2005 ............ 149 1995-2015 ........................48 12 Collagen Fillers Demand 2 Selected Acquisitions 9 Cosmetic Injection in Cosmetic Surgery .......... 102 & Divestitures .................. 156 Demand by Type .................50 13 Other Tissue Fillers Demand 3 Selected Cooperative10 Botulinum Toxin in Cosmetic Surgery .......... 103 Agreements ..................... 161 Injection Demand ...............51 Click here to purchase onlinePage 3 Order now, click here!
  4. 4. Study #2099 September 2006 $4300 Cosmetic Surgery Products 226 Pages US Industry Study with Forecasts to 2010 & 2015Best opportunities in cosmetic surgery products are expected in nonsurgical procedures (e.g., injections,dermal resurfacing and microdermabrasion) due to consumer preferences for less invasive treatments.US demand to grow 9%annually through 2010 US Cosmetic Surgery Product Equipment 38%America’s obsession with youth is driving Demand, 2005growth in cosmetic procedures, which ($1.6 billion)are forecast to grow 9.1 percent peryear to 17.5 million in 2010, valued at$17.3 billion. Demand for materials andequipment used in these procedures is Injectablesforecast to increase 9.0 percent per year 29%to $2.4 billion. Best opportunities are ex-pected in nonsurgical procedures (suchas injections, dermal resurfacing andmicrodermabrasion) due to consumer Implantspreferences for less invasive treatments. 23%However, demand for surgical productswill continue to be strong in areas suchas implants, where there are no signifi- Wound Care 8%cant alternatives. Other Products2%Injectables to be the achieved extraordinary growth, and Microdermabrasion machines will benefitfastest growing segment these products accounted for 61 percent as a rising number of men and womenInjectables will register the fastest of total tissue filler demand in 2005. wish to have a younger looking complex-growth, with sales forecast to increase Going forward, the aggregate injections ion through a procedure which requiresover 15 percent annually to $935 million segment will benefit from new product little or no recovery time.in 2010. Growth in this sector boomed introductions, most notably tissue fillerswith the introduction of BOTOX (Aller- based on synthetic polymers, that pro- Demand for implants is forecast to risegan) in the 1990s when it was used for vide improved, longer-lasting results. 7.4 percent per year to $515 million in“off label” wrinkle treatments. Further 2010. Gains will be driven by an in-growth was achieved when BOTOX creasing acceptance of plastic surgery,achieved FDA approval for cosmetic Skin procedures, implants positive clinical evaluations affirming theindications in 2002 and hyaluronic acid to also show strong gains safety of implants and a growing desireinjections became available in Decem- In 2005, equipment accounted for 38 to enhance personal appearance tober 2003. Two hyaluronic acid tissue percent of total cosmetic surgery prod- improve self-esteem. Breast implants willfiller products were launched on the US uct demand. Demand will be driven by achieve more rapid gains than other im-market in 2004, one in 2005 and one gains in the use of microdermabrasion plants in part due to the expected returnin 2006. Several others are in develop- machines and a variety of other new of silicone-gel filled breast implants toment, awaiting FDA approval. Since equipment types, as well as continued the US market.2003, hyaluronic acid injections have steady growth in the large laser market. Copyright 2006 The Freedonia Group, Inc. Click here to purchase onlinePage 4 Order now, click here!
  5. 5. Study #2099 September 2006 $4300 Cosmetic Surgery Products 226 Pages US Industry Study with Forecasts to 2010 & 2015 Sample Table, TABLE III-3 Text & Forecast COSMETIC RESHAPING PROCEDURES DEMAND BY TYPE Item 1995 2000 2005 2010 2015 Resident Population (mil persons) 266 282 296 310 323 reshaping/000 capita 1.5 2.0 2.4 2.7 3.0 RAW MATERIALS Cosmetic Reshaping (000) 390 565 700 830 955 Nose Reshaping 228 291 380 460 530 Eyelid Reshaping 120 210 230 250 270 Collagen Breast Reduction 29 42 60 80 105 Demand for collagen (excluding autologous) in cosmetic surgery Other 13 22 30 40 50 applications will remain flat at $25 million in 2010. Use as an inject- able tissue filler will continue to account for most demand, although$/procedure this SamPLE SamPLE market will register little growth due to competition from other newly developed tissue fillers, especially hyaluronic acid. Other applications 2870 2715 3245 3465 3690 TabLE Cosmetic Reshaping (mil $) 1120 1535 2270 28753525 TExT for collagen, including tissue adhesives and dressings, are expected Nose Reshaping register faster gains, although these will remain niche markets. While to 640 830 1325 1655 1960 Eyelid Reshaping 310 470 585 700 835 overall growth will be tepid, demand for human collagen will record Breast Reduction 140 185 290 420 600 strong gains as end users move away from animal-derived products.Other 30 50 70 100 130 Collagen is a gelatinous protein complex from which body tissues are formed. The substance participates in the production of skin, internal organs and bones by joining cells together and fixing their location. Col- lagen injections or implants derived from cows are designed to augment lip fullness, minimize scars and reduce lines, such as frown lines, crow’s feet and smile lines, by replacing the natural collagen lost by the skin due to acne blemishes and the passage of time. However, the implants themselves are subject to the aging process and, consequently, supple- mental treatments are necessary after the initial injection, two to four times per year on the average, in order to maintain the desired results. Allergic reactions are the most common side effect of these procedures, with a small percentage of patients exposed to the risk of contracting the serious autoimmune disorder systemic lupus erythematosus. “The number of lift and tuck procedures performed in the US is expected to in- Injectable collagen is generally produced in liquid form from cow crease 6.5 percent annually to 725,000 in hides, although the possibility of allergic reactions and concerns about the role of bovine products in the spread of the human variant of mad 2010, with a market value of $3.3 billion. cow disease have prompted efforts directed at the development of colla- Growth will be driven by positive demo- gen products from human tissue as well as competing synthetic substanc- graphics, in particular a baby boomer es. For example, in 2003, Inamed received FDA approval for two human generation which values a youthful-look- collagen-based injectable dermal fillers, tradenamed COSMODERM and ing appearance and has the disposable 138 Copyright 2006 The Freedonia Group, Inc. income to remedy the effects of aging. New technologies will also enhance growth. For example, ...” --Section III, pg. 35 Click here to purchase onlinePage 5 Order now, click here!
  6. 6. Study #2099 September 2006 $4300 Cosmetic Surgery Products 226 Pages US Industry Study with Forecasts to 2010 & 2015 Sample Profile, TABLE IV-8 Table & Chart COSMETIC SURGERY INJECTABLES DEMAND (million dollars) Item 1995 2000 2005 2010 2015 Cosmetic Injection Procedures (000) 935 2200 5230 9200 14370 $ injectable/procedure 59 63 88 102 108 Cosmetic Injectables Demand Botulinum Toxin 55 5 SamPLE 138 60 460 935 270 605 1555 975 Tissue Fillers Other 30 20 TabLE302 45 33 164 26 28 551 29 % injectables 12.9 15.0 29.4 38.8 44.2 Total Cosmetic Surgery Products 425 923 1565 2410 3515 COMPANY PROFILES Candela Corporation 530 Boston Post Road Wayland, MA 01778 508-358-7400 http://www.candelalaser.com Revenues: $124 million (FY 2005) SamPLE US Revenues: $85 million (FY 2005) Research and Development Expenditures: $7 million (FY 2005) Employment: 310 (FY 2005)PrOFILE Key Products: laser systems for cosmetic/aesthetic surgery applications TABLE VI-1 Candela is a developer, manufacturer and marketer of advanced US COSMETIC SURGERY PRODUCT aesthetic laser and light-based systems. The Company’s products are MARKET SHARE BY COMPANY, 2005 used to perform a range of aesthetic and cosmetic procedures, as well ($1.6 billion) as to treat a number of related medical conditions. In addition, the Company provides product-related services and operates skin care cen- ters that offer cosmetic laser treatments. Candela’s products are sold primarily to plastic and cosmetic surgeons, dermatologists, and other medical practitioners. 32% Allergan The Company’s laser systems and other products, which had Market Others revenues of $102 million in 2005, can be used for hair removal, rosacea 49% Leaders SamPLE treatment, the treatment of veins and vascular lesions, scar and stretch 51% mark removal, wrinkle reduction, and acne and psoriasis treatment ap- CharT 12% Mentor plications, among others. Specific laser systems from Candela include ALEXLAZR, C-BEAM, GENTLELASE, GENTLEYAG, SMOOTH- 7% Medicis BEAM and VBEAM varieties. ALEXLAZR Q-switched, short-pulse solid-state alexandrite la- sers, which can be used to remove multicolored tattoos and pigmented 172 Copyright 2006 The Freedonia Group, Inc. Click here to purchase onlinePage 6 Order now, click here!
  7. 7. Order InfOrmatIOnFive Convenient Ways to Order INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS ONLINE: www.freedoniagroup.com Free Handling & Shipping Credit Card Orders There is NO charge for handling or UPS shipping For convenience, Freedonia accepts American Ex- MAIL: Print out and complete the order in the US. Expect delivery in 3 to 5 business days. press, MasterCard or Visa. Credit card purchases form and send to The Freedonia Group Outside the US, Freedonia provides free airmail must include account number, expiration date and (see address at the bottom of this form) service. Express delivery is available at cost. authorized signature. PHONE: Call toll free, 800.927.5900 Orders Outside of the US Save 15% (US) or +1 440.684.9600 Checks must be made payable in US funds, If you order three (3) different titles at the same drawn against a US bank and mailed directly to time, you can receive a 15% discount. If your FAX: +1 440.646.0484 (US) The Freedonia Group. For wire transfers please order is accompanied by a check or wire transfer, contact our customer service department at info@ you may take a 5% cash discount (discounts do EMAIL: info@freedoniagroup.com freedoniagroup.com. Credit cards accepted. not apply to Corporate Use Licenses). Corporate Use License Now every decision maker in your organization can act on the key intelligence found in all Freedonia studies. For an additional $2300, companies receive unlimited use of an electronic Click here to learn more about version (PDF) of the study. Place it on your intranet, e-mail it to coworkers around the world, the Corporate Use License or print it as many times as you like, Order fOrm F-WEB.2099 Name Cosmetic Surgery Products ..................................... $4300 Title Corporate Use License (add to study price) * +$2300 Company Additional Print Copies @ $500 each * Total (including selected option) $ Division Enclosed is my check (5% discount) drawn on a US bank and payable to The Freedonia Group, Inc., in US funds (Ohio residents add 7.75% sales tax) Street (No PO Box please) Bill my company American Express MasterCard Visa City/State/Zip MM YY Country Credit Card # Expiration Phone Fax Signature Email* Please check appropriate option and sign below to order an electronic Individual Use License Agreementversion of the study. The undersigned hereby represents that the above captioned study will be used by only ___ individual(s) who are employees of the company and that the study will not be loaded on a network for multiple users. In the event Corporate Use License Agreement that usage of the study changes, the Company will promptly notify Freedo-The above captioned study may be stored on the company’s intranet or nia of such change and will pay to Freedonia the appropriate fee based onshared directory, available to company employees. Copies of the study may Freedonia’s standard fee schedule then in effect. Note: Entire company cor-be made, but the undersigned represents that distribution of the study will porate use license, add $2300; one additional user, add $500; two additionalbe limited to employees of the company. users, add $1000; three additional users, add $1500.Signature Signature The Freedonia Group, Inc. 767 Beta Drive • Cleveland, OH • 44143-2326 • USA • Web site: www.freedoniagroup.com Tel US: 800.927.5900 or +1 440.684.9600 • Fax: +1 440.646.0484 • e-mail: info@freedoniagroup.comPage 7
  8. 8. INDUSTRY MARKET RESEARCH FOR BUSINESS LEADERS, STRATEGISTS, DECISION MAKERS Other StudieS About The Freedonia Group Implantable medical Devices The Freedonia Group, Inc., is a leading international industry market research com- US medical implant demand will rise 9.3% yearly pany that provides its clients with information and analysis needed to make informed through 2011. Cardiac implants will remain the top- strategic decisions for their businesses. Studies help clients identify business oppor- selling group, led by stents and defibrillators. Bone cement, tissue and spinal implants will pace gains in tunities, develop strategies, make investment decisions and evaluate opportunities the orthopedic segment. Other fast-growing types in- and threats. Freedonia research is designed to deliver unibiased views and reliable clude neurological stimulators, cochlear devices and gastric bands. This study analyzes the $27.9 billion outlooks to assist clients in making the right decisions. Freedonia capitalizes on US medical implant industry, with forecasts for 2011 the resources of its proprietary in-house research team of experienced economists, and 2016 by material and product. It also evaluates market share and profiles major players. professional analysts, industry researchers and editorial groups. Freedonia covers a #2255 ................... 10/2007..................... $4500 diverse group of industries throughout the United States, the emerging China mar- ket, and other world markets. Industries analyzed by Freedonia include: Dental Equipment • Chemicals • Plastics • Life Sciences • Packaging • Building Materials • Security US demand for dental equipment will grow 3.8% & Electronics • Industrial Components & Equipment • Automotive & Transportation annually through 2011, aided by favorable population trends and strong interest in technology updates. Equipment • Household Goods • Energy/Power Equipment In general, advanced equipment such as lasers, intra-oral cameras, digital radiography and CAD/CAM systems will lead gains. Dental offices will remain the Click here to learn more about Freedonia largest market and grow the fastest. This study ana- lyzes the $2.4 billion US dental equipment industry to 2011 and 2016 by product and market. It also evalu- ates market share and profiles major players. #2179 ................... 04/2007..................... $4400 Freedonia Custom Research Freedonia Custom Research delivers the same high quality, thorough and unbiased medical Imaging assessment of an industry or market as an industry study. Since the research initia- (Equipment, agents, Consumbles) tive is based upon a company’s specific needs, companies harness Freedonia’s US demand for medical imaging products will grow research capabilities and resources to answer unique questions. When you leverage 6% annually through 2010 based on technological the results of a Freedonia Custom Research engagement, you are able to obtain advances, aging demographics and changing health care approaches. Equipment will outpace consum- important answers to specific questions and issues associated with: mergers and ables, led by CT scanners and by MRI and PET ma- acquisitions, new product launches/development, geographic expansion, entry into chines. Radiopharmaceuticals will lead gains among consumables. This study analyzes the $16 billion new markets, strategic business planning, and investment and funding decisions. US medical imaging product industry for 2010 and 2015 by type and market. It also evaluates company Freedonia Custom Research is ideal for companies seeking to make a strategic dif- market share and profiles major players. #2137 ................... 12/2006..................... $4400 ference in the status quo and focus on future business growth. Working side by side with clients, Freedonia’s team is able to define a research project that is custom-tai- lored to answer specific questions and provide the basis from which a company can Cosmeceuticals make informed business decisions. US cosmeceuticals demand will grow 8.5% annually, propelled by a stream of new products offering age- defying and other appearance-enhancing benefits. Click here to learn more about Custom Research Skin care products will remain dominant while profes- sional products will grow the fastest. BOTOX and hyaluronic acid will lead gains among cosmeceutical chemicals. This study analyzes the $5.4 billion US cosmeceutical industry for 2010 and 2015 by product and chemical. It also evaluates company market share and profiles leading players. #2114 ................... 10/2006..................... $4400 biocompatible materials US demand for biocompatible materials will grow 6.6% yearly through 2010. Synthetic polymers will remain dominant based on quality, performance and cost advantages in most applications. Ceramics will grow the fastest, driven by improved properties and processing ease. Hyaluronic acid and collagen will pace the natural polymer segment. This study analyzes the $2.7 billion US biocompatible industry to 2010 and 2015 by material and application. It also evaluates market share and profiles major players. #2111 ................... 09/2006..................... $4400 Click here for complete title list Click here to visit freedoniagroup.comPage 8 The Freedonia Group, Inc. 767 Beta Drive • Cleveland, OH • 44143-2326 • USA • Web site: www.freedoniagroup.com Tel US: 800.927.5900 or +1 440.684.9600 • Fax: +1 440.646.0484 • e-mail: info@freedoniagroup.com

×